deltatrials
Completed NA NCT00080145

RUPP PI PDD: Drug and Behavioral Therapy for Children With Pervasive Developmental Disorders

Risperidone and Behavioral Therapy in Treatment of Children and Adolescents With Autistic Disorder

Sponsor: National Institute of Mental Health (NIMH)

Conditions Child Development Disorders, Pervasive
Interventions Behavior Therapy Risperidone
Updated 6 times since 2017 Last updated: Aug 15, 2013 Started: Feb 29, 2004 Primary completion: Sep 30, 2007 Completion: Sep 30, 2007

This NA trial investigates Child Development Disorders, Pervasive and is currently completed. National Institute of Mental Health (NIMH) leads this study, which shows 6 recorded versions since 2004 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Jan 2021 — Jul 2024 [monthly]

    Completed NA

  4. Jun 2018 — Jan 2021 [monthly]

    Completed NA

  5. Feb 2017 — Jun 2018 [monthly]

    Completed NA

▶ Show 1 earlier version

  1. Jan 2017 — Feb 2017 [monthly]

    Completed NA

    First recorded

Feb 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Institute of Mental Health (NIMH)
  • Yale University
Data source: Yale University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Columbus, United States
  • • Indianapolis, United States
  • • New Haven, United States